TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,319,416 | +36.4% | 355,683 | +38.7% | 0.00% | +100.0% |
| Q2 2023 | $4,634,029 | +56.5% | 256,460 | +8.9% | 0.00% | 0.0% |
| Q1 2023 | $2,960,675 | +101085.1% | 235,530 | +18.0% | 0.00% | 0.0% |
| Q4 2022 | $2,926 | -99.9% | 199,676 | +40.4% | 0.00% | 0.0% |
| Q3 2022 | $2,434,000 | +47.5% | 142,207 | +25.9% | 0.00% | 0.0% |
| Q2 2022 | $1,650,000 | +240.2% | 112,975 | +291.5% | 0.00% | – |
| Q1 2022 | $485,000 | +140.1% | 28,855 | +221.0% | 0.00% | – |
| Q4 2021 | $202,000 | – | 8,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,001,585 | $29,343,236 | 4.26% |
| Vivo Capital, LLC | 2,262,200 | $33,164 | 3.82% |
| Cormorant Asset Management, LP | 1,736,422 | $25,456 | 1.70% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,205,146 | 1.63% |
| Sands Capital Ventures, LLC | 260,000 | $3,812 | 1.04% |
| RTW INVESTMENTS, LP | 2,548,125 | $37,355,513 | 0.76% |
| Perceptive Advisors | 1,296,416 | $19,005,459 | 0.53% |
| Ghost Tree Capital, LLC | 80,000 | $1,173,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,412,977 | 0.40% |
| TimesSquare Capital Management, LLC | 1,429,310 | $20,954 | 0.30% |